Live feed
·
INSIDERFilingvia Quantisnow
Ayala Pharmaceuticals Inc. logo

SEC Form 4: Maimon Yossi returned 69,872 shares to the company, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
AYLA· Ayala Pharmaceuticals Inc.
Consumer Discretionary
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AYLA (Ayala Pharmaceuticals Inc.) and more on Quantisnow.